Atria Investments’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.41M | Buy |
9,035
+1,116
| +14% | +$302K | 0.03% | 635 |
|
|
2025
Q4 | $1.99M | Sell |
7,919
-323
| -4% | -$85.8K | 0.02% | 722 |
|
|
2025
Q3 | $2.37M | Sell |
8,242
-1,978
| -19% | -$530K | 0.03% | 660 |
|
|
2025
Q2 | $2.68M | Buy |
10,220
+701
| +7% | +$171K | 0.03% | 608 |
|
|
2025
Q1 | $2.22M | Sell |
9,519
-12
| -0.1% | -$2.91K | 0.03% | 660 |
|
|
2024
Q4 | $2.19M | Buy |
9,531
+2
| +0% | +$459 | 0.03% | 642 |
|
|
2024
Q3 | $2.13M | Sell |
9,529
-35
| -0.4% | -$7.69K | 0.03% | 644 |
|
|
2024
Q2 | $1.95M | Buy |
9,564
+714
| +8% | +$145K | 0.03% | 656 |
|
|
2024
Q1 | $1.93M | Buy |
8,850
+1,285
| +17% | +$283K | 0.03% | 668 |
|
|
2023
Q4 | $1.72M | Buy |
7,565
+523
| +7% | +$110K | 0.03% | 656 |
|
|
2023
Q3 | $1.42M | Sell |
7,042
-360
| -5% | -$75.9K | 0.03% | 701 |
|
|
2023
Q2 | $1.53M | Buy |
7,402
+4
| +0.1% | +$776 | 0.03% | 657 |
|
|
2023
Q1 | $1.46M | Buy |
7,398
+925
| +14% | +$190K | 0.03% | 658 |
|
|
2022
Q4 | $1.31M | Buy |
6,473
+623
| +11% | +$122K | 0.03% | 657 |
|
|
2022
Q3 | $1.03M | Buy |
5,850
+285
| +5% | +$58.3K | 0.02% | 715 |
|
|
2022
Q2 | $1.12M | Sell |
5,565
-1,166
| -17% | -$249K | 0.02% | 707 |
|
|
2022
Q1 | $1.52M | Buy |
6,731
+559
| +9% | +$131K | 0.03% | 669 |
|
|
2021
Q4 | $1.67M | Buy |
6,172
+181
| +3% | +$44.8K | 0.03% | 642 |
|
|
2021
Q3 | $1.45M | Sell |
5,991
-5,985
| -50% | -$1.51M | 0.03% | 654 |
|
|
2021
Q2 | $2.84M | Buy |
11,976
+1,650
| +16% | +$376K | 0.05% | 391 |
|
|
2021
Q1 | $2.26M | Sell |
10,326
-394
| -4% | -$79.1K | 0.05% | 415 |
|
|
2020
Q4 | $1.88M | Buy |
10,720
+4,360
| +69% | +$753K | 0.05% | 435 |
|
|
2020
Q3 | $1.03M | Sell |
6,360
-2,197
| -26% | -$348K | 0.03% | 563 |
|
|
2020
Q2 | $1.22M | Buy |
8,557
+1,298
| +18% | +$180K | 0.04% | 448 |
|
|
2020
Q1 | $788K | Sell |
7,259
-347
| -5% | -$50K | 0.06% | 267 |
|
|
2019
Q4 | $1.1M | Buy |
7,606
+3,176
| +72% | +$459K | 0.03% | 490 |
|
|
2019
Q3 | $639K | Buy |
4,430
+238
| +6% | +$34.7K | 0.02% | 525 |
|
|
2019
Q2 | $590K | Buy |
4,192
+1,521
| +57% | +$212K | 0.02% | 536 |
|
|
2019
Q1 | $351K | Buy |
2,671
+661
| +33% | +$81.4K | 0.01% | 636 |
|
|
2018
Q4 | $218K | Sell |
2,010
-149
| -7% | -$20K | 0.01% | 781 |
|
|
2018
Q3 | $322K | Sell |
2,159
-988
| -31% | -$150K | 0.01% | 750 |
|
|
2018
Q2 | $485K | Sell |
3,147
-294
| -9% | -$44.4K | 0.02% | 582 |
|
|
2018
Q1 | $478K | Buy |
3,441
+388
| +13% | +$57K | 0.02% | 523 |
|
|
2017
Q4 | $418K | Buy |
3,053
+256
| +9% | +$33.8K | 0.02% | 532 |
|
|
2017
Q3 | $363K | Buy |
2,797
+696
| +33% | +$92.8K | 0.02% | 539 |
|
|
2017
Q2 | $278K | Buy |
+2,101
| New | +$257K | 0.02% | 587 |
|
|
2016
Q3 | – | Sell |
-2,638
| Closed | -$300K | – | 566 |
|
|
2016
Q2 | $300K | Buy |
+2,638
| New | +$284K | 0.03% | 360 |
|
Other funds holding LH
VCM
VPM
Atria Investments's LH Position: Q1 2026 in Review
Atria Investments increased its Labcorp (LH) stake by 14% in Q1 2026, buying an estimated $302K and bringing the position to 9,035 shares worth $2.41M. The position accounts for 0.03% of the portfolio, ranked #635.
Atria Investments first reported a position in LH in Q2 2016 and has held it in 37 quarters since. The position peaked at $2.84M in Q2 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Atria Investments held 9,035 shares of Labcorp worth $2.41M as of Q1 2026.
- Atria Investments bought 1,116 Labcorp shares in Q1 2026, an estimated $302K.
- Labcorp made up 0.03% of Atria Investments's portfolio in Q1 2026, its #635 holding.
- Atria Investments first reported a position in Labcorp in Q2 2016 and has held it in 37 quarters since.
- Atria Investments's Labcorp position peaked at $2.84M in Q2 2021.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.